Panelists:
Deepak Voora, MD (Duke Center for Applied Genomics and Precision Medicine)
Robert Shuck, PhD (Division of Translational and Precision Medicine at the US FDA)
Gary Proctor, MD (Carelon)
Moderated by: Rachele Hendricks Sturrup, DHSc, MSc, MA (Duke Margolis Institute for Health Policy)
Abstract: There are many personal and health system level factors that affect the widespread adoption of pharmacogenomics informed treatments in psychiatric care settings. However, many ethical, legal, and social implications (ELSI) questions and challenges remain under-explored in both research and practice settings. For instance, who has access to pharmacogenomics research, testing and/or informed treatment in psychiatric care settings and why? What are ethics and equity implications to consider and address regarding pharmacogenomic testing in psychiatric care settings?
ELSI Friday Forum is sponsored by NHGRI
Location and Address
Online